Literature DB >> 173046

Metabolism of dehydroepiandrosterone by hormone dependent and hormone independent human breast carcinoma.

Y J Abul-Hajj.   

Abstract

The metabolism of 7alpha-3H-dehydroepiandrosterone was studied in six human breast carcinomas in vitro. All mammary tumors transformed DHA to testosterone, dihydrotestosterone, 5alpha-androstane-3alpha, 17beta-diol and 5alpha-androstane-3,17-dione. Of the tumors investigated, three estrogen receptor-negative tumors converted DHA to estradiol and only one estrogen receptor-positive tumor produced estradiol from DHA. Observations on the relationship of androgen metabolism and hormone dependency are discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 173046     DOI: 10.1016/0039-128x(75)90068-9

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  5 in total

1.  In vivo influence of androgens on the cell kinetics and chromatin pattern of the MXT mouse mammary tumor treated or not by aminoglutethimide.

Authors:  Y de Launoit; R Kiss
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

2.  Tumour steroid hormone synthesis and estrogen receptor status in breast cancer patients.

Authors:  R C Mason; D A Burns; W R Miller; R A Hawkins; A P Forrest
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

3.  Androgen metabolism and apocrine differentiation in human breast cancer.

Authors:  W R Miller; J Telford; J M Dixon; A A Shivas
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

4.  Localization of diazepam-binding inhibitor and peripheral type benzodiazepine binding sites in the rat ovary.

Authors:  D Toranzo; Y Tong; M C Tonon; H Vaudry; G Pelletier
Journal:  Anat Embryol (Berl)       Date:  1994-10

5.  Conversion to estriol in "normal", benign and malignant human breast tissues.

Authors:  R Seshadri; N D Bagli-Vania; J N Suraiya; N A Sheth
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.